These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 13635385)
1. Experimental evaluation of the toxicity of hypaque, urokon, and thorotrast incident to their use as aortographic contrast media. KILLEN DA; LANCE EM; OWENS G Surg Forum; 1958; 9():337-9. PubMed ID: 13635385 [No Abstract] [Full Text] [Related]
2. Relative suitability of urokon 70 per cent and hypaque 90 per cent for use as aortographic contrast media. KILLEN DA; LANCE EM; OWENS G Surgery; 1959 Mar; 45(3):436-44. PubMed ID: 13635221 [No Abstract] [Full Text] [Related]
3. Toxic reactions incident to urokon aortography as related to the volume of contrast medium injected. KILLEN DA; FOSTER JH; SCOTT HW Ann Surg; 1962 Mar; 155(3):472-6. PubMed ID: 14455922 [No Abstract] [Full Text] [Related]
4. Investigation of means to prevent spinal cord and renal damage incident to Urokon aortography. KILLEN DA; LANCE EM Surgery; 1962 Mar; 51():338-46. PubMed ID: 14455924 [No Abstract] [Full Text] [Related]
5. [Toxicity testing of contrast media for angiography in newborn rats. 3. Comparative testing of 4 media]. Oberholzer F; Probst H; Breitenstein R; Kaufmann HJ Biol Neonat; 1966; 10(1):47-54. PubMed ID: 5919852 [No Abstract] [Full Text] [Related]
6. Transient hemiplegia in cerebral angiography, an unusual reaction to hypaque. SELKER RG; MISHKIN MM Pa Med J; 1961 Jul; 64():880-1. PubMed ID: 13749901 [No Abstract] [Full Text] [Related]
8. Experimental appraisal of the agents employed as angiocardiographic and aortographic contrast media. II. Nephrotoxicity. KILLEN DA; LANCE EM Surgery; 1960 Feb; 47():260-5. PubMed ID: 14409066 [No Abstract] [Full Text] [Related]
9. Experimental appraisal of the agents employed as angiocardiographic and aortographic contrast media. I. Neurotoxicity. LANCE EM; KILLEN DA Surgery; 1959 Dec; 46():1107-17. PubMed ID: 14413747 [No Abstract] [Full Text] [Related]
10. A clinical comparison of the diiodo-compound umbradil and the tri-iodo-compound urokon in 133 cerebral angiographies. Report of a severe renal complication following cerebral angiography with urokon. Presthus J; Bruland H Acta Psychiatr Scand; 1959; 34(4):479-88. PubMed ID: 14434782 [No Abstract] [Full Text] [Related]
11. Glucose protection of the canine kidney against urokon injury during abdominal aortography. LANCE EM; KILLEN DA Surg Forum; 1960; 11():139-40. PubMed ID: 13758616 [No Abstract] [Full Text] [Related]
12. Experimental evaluation of a new angiographic contrast medium--isopaque 440. Welborn MB; Sewell RA; Killen DA; Foster JH Am J Roentgenol Radium Ther Nucl Med; 1967 Sep; 101(1):224-8. PubMed ID: 6037337 [No Abstract] [Full Text] [Related]
13. Extravasation of contrast medium as roentgen criterion of cardiac necrosis in dogs following intracoronary injection of Urokon. OPPENHEIMER MJ; HARAKAL C; SHERWIN R; HOWDEN L; WINTERS W; STAUFFER HM Am J Roentgenol Radium Ther Nucl Med; 1960 Nov; 84():929-36. PubMed ID: 13731061 [No Abstract] [Full Text] [Related]
14. A comparison of the toxicity of various agents used in coronary arteriography. FLOM RS; MACLEAN LD; LEWIS FJ J Lancet; 1957 Nov; 77(11):431-3. PubMed ID: 13476048 [No Abstract] [Full Text] [Related]
15. [Hypaque, new product of triiodide contrast media for urography & angiography]. DELAY JB Praxis; 1957 Aug; 46(33):728-30. PubMed ID: 13484689 [No Abstract] [Full Text] [Related]